TrialBMC pharmacology & toxicology2023
A phase I study comparing the biosimilarity of the pharmacokinetics and safety of recombinant humanized anti-vascular endothelial growth factor monoclonal antibody injection with Avastin
Hongtao Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.